<DOC>
	<DOCNO>NCT02323451</DOCNO>
	<brief_summary>This study evaluate safety efficacy investigational product treatment knee Osteoarthritis . Half participant receive medical chitosan , half receive sodium hyaluronate .</brief_summary>
	<brief_title>Medical Chitosan Sodium Hyaluronate Knee Osteoarthritis ( CHOOSE )</brief_title>
	<detailed_description>Medical chitosan sodium hyaluronate form reticular layer cover joint surface , alleviate joint friction pain . For medical chitosan , half-life long sodium hyaluronate , interval time intra-articular injection longer .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Chitosan</mesh_term>
	<criteria>1 . Males females age 4075 year old 2 . Conforming diagnosis standard American College Rheumatology 2009： knee pain osteophyte determine Xray , least one follow items： 50 year old morning stiffness le 30 minute knee joint fricative move 3 . The study knee score 4090 mm 100 mm measure VAS side less 40mm walk flat ground . 4 . The study knee score 1 , 2 3 determined radiological KellgrenLawrence grade scale . 5 . Patients treatment requirement obey therapeutic schedule 6 . Body mass index ( BMI ) ≤35kg/m2。 7 . Able follow clinical observation follow . 8 . The subject able understand sign inform consent fully understand study , disease , investigational drug , therapeutic schedule potential risk . 1 . Positive sign swell float patella test，and obvious effusion knee joint clinical . 2 . Other inflammatory pain disease knee joint , rheumatism/ rheumatoid arthritis , psoriatic arthritis , gout , hemophilic arthritis , etc . 3 . Pain disease knee joint , except osteoarthritis , intraarticular tumor , villonodular synovitis , joint trauma , etc . 4 . Pregnant lactating female . 5 . Participants suffer serious cardiovascular disease ( Sudden cerebral infarction sequela myocardial infarction within recent 6 month ) , hepatic disease , kidney disease；Participants whose ALT AST twice twice upper limit normal value；Participants whose serum creatinine exceed upper limit normal value；Participants suffer dysfunction blood coagulation ( thrombocytopenia , bleeder disease , etc . ) 6 . Participants systemic infection infectious disease . 7 . Participants suffer serious skin defect ulcer around study knee joint . 8 . Participants suffer typical varus valgus deformity lack articular cavity . 9 . Participants diabetes inject insulin good enough control blood glucose ( FBG ( fast bloodglucose ) ≥10mmol/L . ) 10 . Participants suffer cancer ( within 5 year ) Alzheimer 's disease . 11 . Participants score 0 4 study knee joint evaluate radiological KellgrenLawrence grade scale . 12 . Participants hormone drug within 2 week analgesic drug within 1 week trial take part clinical trial . 13 . Participants whose study knee receives articular cavity therapy within 3 month , contain intra articular administration , articular irrigation arthroscopic surgery 14 . Participants allergy experimental drug . 15 . Participants suitable trial judge researcher .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>